Coverage
-
August 01, 2019
A D.C. federal judge on Thursday chucked a challenge to the U.S. Food and Drug Administration's limits on drug compounding with the hormone vasopressin, rejecting assertions that the agency is improperly policing the practice of medicine.
2 other articles on this case.
View all »